6218 studies found for:    Grade
Show Display Options
Rank Status Study
1 Enrolling by invitation Permeability Map to Distinguish Progression From Pseudoprogression in High-Grade Glioma
Condition: High Grade Glioma
Intervention:
2 Active, not recruiting External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas
Condition: Brain Cancer
Intervention: Other: cetuximab in conjunction with external beam radiation therapy, followed by cetuximab and irinotecan
3 Active, not recruiting A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas
Conditions: Newly Diagnosed High-Grade Gliomas;   Diffuse Intrinsic Pontine Glioma
Interventions: Drug: Temozolomide;   Drug: Bevacizumab;   Drug: Irinotecan
4 Recruiting Radiofrequency Ablation for Barrett Oesophagus With Low Grade Dysplasia
Conditions: Barrett Oesophagus;   Low Grade Dysplasia
Interventions: Procedure: Endoscopic radiofrequency ablation;   Other: Endoscopic surveillance
5 Not yet recruiting Improving IVF Embryo Quality Grading Using Polarized Light
Condition: Infertility
Intervention: Procedure: Embryo selection based on polscope grading or morphology
6 Completed Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System
Condition: Ovarian Cancer
Intervention:
7 Active, not recruiting
Has Results
Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
Conditions: Childhood High-grade Cerebral Astrocytoma;   Childhood Oligodendroglioma;   Childhood Spinal Cord Neoplasm;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Medulloblastoma
Interventions: Biological: bevacizumab;   Drug: irinotecan hydrochloride;   Radiation: fludeoxyglucose F 18
8 Completed
Has Results
Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus
Conditions: Anal Cancer;   Precancerous Condition
Interventions: Drug: cidofovir;   Genetic: DNA methylation analysis;   Genetic: gene expression analysis;   Genetic: polymerase chain reaction;   Procedure: biopsy;   Procedure: histopathologic examination
9 Completed
Has Results
A Randomized Study of Iodine-131 Anti-b1 Antibody Versus Anti-b1 Antibody in Chemotherapy-relapsed/Refractory Low-grade or Transformed Low-grade Non-Hodgkin's Lymphoma (NHL)
Condition: Lymphoma, Non-Hodgkin
Intervention: Biological: Iodine-131 Anti-B1 Antibody Versus Anti-B1 Antibody in Chemotherapy-Relapsed/Refractory Low-Grade or Transformed Low-Grade Non-Hodgkin's Lymphoma (NHL)
10 Completed The Effects of End-of-range Grade A+ Mobilization Following Acute Primary TKA
Condition: Osteoarthritis, Knee
Intervention: Other: grade A+ knee mobilization
11 Recruiting Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas
Conditions: High Risk WHO Grade II Glioma;   Recurrent/Post-Chemotherapy WHO Grade II Glioma
Interventions: Biological: Tumor Lysate Vaccine;   Drug: Imiquimod
12 Completed Study of Natural History of Human Papillomavirus (HPV) Infections in Adult Women With Recurrent Conizations in Norway
Conditions: Microinvasive Carcinomas and Invasive Cervical Cancer;   High Grade Cervical Lesions
Intervention: Procedure: Cancer Registry of Norway (database)
13 Completed Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma
Conditions: Contiguous Stage II Grade 1 Follicular Lymphoma;   Contiguous Stage II Grade 2 Follicular Lymphoma;   Contiguous Stage II Marginal Zone Lymphoma;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Nodal Marginal Zone B-cell Lymphoma;   Noncontiguous Stage II Grade 1 Follicular Lymphoma;   Noncontiguous Stage II Grade 2 Follicular Lymphoma;   Noncontiguous Stage II Marginal Zone Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Marginal Zone Lymphoma;   Splenic Marginal Zone Lymphoma;   Stage I Grade 1 Follicular Lymphoma;   Stage I Grade 2 Follicular Lymphoma;   Stage I Marginal Zone Lymphoma;   Stage III Grade 1 Follicular Lymphoma;   Stage III Grade 2 Follicular Lymphoma;   Stage III Marginal Zone Lymphoma;   Stage IV Grade 1 Follicular Lymphoma;   Stage IV Grade 2 Follicular Lymphoma;   Stage IV Marginal Zone Lymphoma;   Waldenstrom Macroglobulinemia
Interventions: Other: pharmacological study;   Biological: rituximab;   Drug: dexamethasone;   Other: laboratory biomarker analysis
14 Active, not recruiting Late Effects of Proton Radiation Therapy in Patients With Low-Grade Glioma
Condition: Low Grade Gliomas
Intervention: Radiation: Proton Radiation Therapy
15 Terminated Study of CryoSpray Ablation of Low Grade or High Grade Dysplasia Within Barrett's Esophagus
Conditions: Barrett's Esophagus;   High Grade Dysplasia;   Low Grade Dysplasia
Intervention: Device: CryoSpray Ablation System (510(k) NO: K070893)
16 Withdrawn Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: sodium phenylacetate and sodium benzoate injection 10% / 10%;   Drug: placebo solution (10% dextrose)
17 Recruiting PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
Conditions: Pediatric Recurrent Progressive Low-grade Gliomas;   Pediatric Progressive Low-grade Gliomas
Intervention: Drug: Everolimus
18 Completed Protocol to Distinguish Tumor Recurrence From Treatment-Related Necrosis in Patients With High Grade Gliomas
Condition: Recurrent High Grade Gliomas
Intervention: Device: 3T MRI
19 Completed Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer
Condition: Invasive Breast Cancer
Interventions: Other: Sampling of tumor tissue;   Other: Sampling of tumor tissue after breast cancer surgery;   Procedure: Sampling of tumor tissue after breast cancer surgery
20 Completed
Has Results
Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin's Lymphoma
Condition: Lymphoma, Non-Hodgkin
Intervention: Biological: Tositumomab and Iodine I 131 Tositumomab

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years